Latest News

  • TECHNOLOGY

    10 Dec 2025

    AI Sparks a New mRNA Design Race

  • PARTNERSHIPS

    9 Dec 2025

    Two mRNA Titans Plot a Faster Path to Cancer Breakthroughs

  • INSIGHTS

    8 Dec 2025

    The New Contest for Homegrown Drug Power

  • RESEARCH

    5 Dec 2025

    mRNA Cancer Advance Hints at New Path for In-Body Therapeutics

HHS Shift Reshapes Momentum and Strategy Across mRNA Sector

Person walking toward large federal building with strong morning shadows

REGULATORY

4 Dec 2025

HHS exit from key BARDA vaccine projects forces mRNA players to rethink priorities and chase new paths for growth

mRNA strand connecting to virus and syringe representing genetic therapy

INNOVATION

14 Nov 2025

Can mRNA Rewrite the Future of Rare Disease Care?

US labs and biotech firms push mRNA deeper into rare disease therapy, stirring hope and investment

3D illustration of an mRNA strand, syringe, and virus particle symbolizing mRNA research.

INSIGHTS

10 Nov 2025

What BioNTech’s CureVac Deal Says About mRNA’s Future

BioNTech’s $1.25B CureVac deal pushes mRNA beyond vaccines toward cancer treatment

Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy

PARTNERSHIPS

20 Aug 2025

Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy

AbbVie's Capstan buy signals a bold leap into in-vivo mRNA therapies, reshaping the race for next-gen autoimmune treatments.

Early Cancer Trial Puts mRNA in the Spotlight

RESEARCH

14 Aug 2025

Early Cancer Trial Puts mRNA in the Spotlight

Strand's STX-001 shows early tumor-fighting promise as mRNA shifts from vaccines to therapeutics.

mRNA's Next Act: Strand Secures $153M for Cancer Fight

INVESTMENT

9 Aug 2025

mRNA's Next Act: Strand Secures $153M for Cancer Fight

Boston biotech secures major funding as investors back oncology applications of mRNA

The Rare-Disease Frontier Where mRNA Is Headed

INSIGHTS

6 Aug 2025

The Rare-Disease Frontier Where mRNA Is Headed

Acuitas pioneers gene-editing delivery for rare disease, signaling mRNA's evolution beyond vaccines.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.